Marbella Pharmacy Launches Vaccine Distribution in Orange County, California
Marbella Pharmacy has received its initial allocation of the Johnson & Johnson vaccine.
[vc_row][vc_column]
Marbella Pharmacy has received its initial allocation of the Johnson & Johnson vaccine.
https://www.youtube.com/watch?v=OdeIK-BSuII
New Brand Supports Strategic Corporate Vision as “One Medivolve” Built for Transformation; Solidifying Mission to Address Gaps in the Nation’s Health System
Developers worked to create new technology known as BlowFISH to detect the presence of the virus through directly testing respiratory droplets. WCNC – TV – NBC
The technology has entered the next phase toward applying for an EUA from the FDA to test for the COVID-19 virus. Medical Product Outsourcing
New platform supports Medivolve’s position as a growing health technology and services company
Acquisition will give Medivolve immediate access to pharmaceutical distribution and CalVax licensing throughout CA; near term COVID-19 vaccination allocations to follow.
https://www.youtube.com/watch?v=STjOgDQMlLo
Toronto, Ontario May 6, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare company that seeks out disruptive technologies, ground-breaking innovations and exclusive partnerships to transform human health management, today announces that a webinar will be held on Tuesday, May 11th at 11 am ET. The webinar will feature newly appointed Medivolve CEO, David Preiner…
New platform supports Medivolve’s position as a growing health technology and services company
Medivolve is well positioned to deliver shareholder value from its equity position in Marvel Diagnostics and the team’s successful development of BlowFISH, a non-invasive exhaled breath diagnostic technology that has cleared the first milestone in a series of clinical tests and has entered the next phase toward applying for an Emergency Use Authorization from the…
Toronto, Ontario April 30, 2021 — Medivolve Inc. (“Medivolve”) (NEO:MEDV; OTC:COPRF; FRA:4NC) a healthcare investment management company that seeks out disruptive technologies, ground-breaking innovations and exclusive partnerships to help combat COVID-19, today announced that David Preiner has been appointed Chief Executive Officer (CEO), effective immediately. Preiner will succeed Doug Sommerville, who will assist as a transitionary…